Restiffic RLS for restless leg syndrome
Patients who participated in the restiffic clinical trial have touched on their experiences with RLS after using our product. Hear what they have to say in the video below.
Statistics from the restiffic clinical trial
- 97% of patients experienced a decrease in the severity of their RLS symptoms.
- Patients exhibited 69% reduction in the severity of symptoms after 6 weeks of using restiffic.
- restiffic was shown to be 40% more effective than the leading drug treatment for RLS.
- Physicians reported observing no side effects in 93% of patients.
MyFace2FaceMD™ is a patient centered telemedicine service, which is committed to providing the highest quality patient care available. Our healthcare services are available to anyone, anywhere, 24/7/365 from your computer, phone, or tablet.